Varadarajan, Shankar ORCID: 0000-0002-8827-6567, Poornima, Paramasivan, Milani, Mateus, Gowda, Krishne, Amin, Shantu, Wang, Hong-Gang and Cohen, Gerry
(2015)
Maritoclax and Dinaciclib inhibit MCL-1 activity and induce apoptosis in both a MCL-1-dependent and -independent manner.
Oncotarget, 6 (14).
pp. 12668-12681.
This is the latest version of this item.
Text
3706-48124-1-PB.pdf - Unspecified Download (8MB) |
|
Atom XML (admin)
2017-05-12T11:19:33Z.atom - Unspecified Access to this file is embargoed until Unspecified. Download (57kB) |
Abstract
The anti-apoptotic BCL-2 family proteins are important targets for cancer chemotherapy. Specific and potent inhibitors of the BCL-2 family, such as ABT-263 (navitoclax) and ABT-199, are only effective against some members of the BCL-2 family but do not target MCL-1, which is commonly amplified in tumors and associated with chemoresistance. In this report, the selectivity and potency of two putative MCL-1 inhibitors, dinaciclib and maritoclax, were assessed. Although both compounds induced Bax/Bak- and caspase-9-dependent apoptosis, dinaciclib was more potent than maritoclax in downregulating MCL-1 and also in inducing apoptosis. However, the compounds induced apoptosis, even in cells lacking MCL-1, suggesting multiple mechanisms of cell death. Furthermore, maritoclax induced extensive mitochondrial fragmentation, and a Bax/Bak- but MCL-1-independent accumulation of mitochondrial reactive oxygen species (ROS), with an accompanying loss of complexes I and III of the electron transport chain. ROS scavengers, such as MitoQ, could not salvage maritoclax-mediated effects on mitochondrial structure and function. Taken together, our data demonstrate that neither dinaciclib nor maritoclax exclusively target MCL-1. Although dinaciclib is clearly not a specific MCL-1 inhibitor, its ability to rapidly downregulate MCL-1 may be beneficial in many clinical settings, where it may reverse chemoresistance or sensitize to other chemotherapeutic agents.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | dinaciclib, maritoclax, MCL-1, apoptosis, mitochondria |
Depositing User: | Symplectic Admin |
Date Deposited: | 28 Jul 2015 12:03 |
Last Modified: | 15 Dec 2022 12:19 |
DOI: | 10.18632/oncotarget.3706 |
Publisher's Statement : | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution, and reproduction in any medium, provided the original author and source are credited. |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/2018084 |
Available Versions of this Item
-
Maritoclax and Dinaciclib inhibit MCL-1 activity and induce apoptosis in both a MCL-1-dependent and -independent manner. (deposited 31 Mar 2015 16:16)
- Maritoclax and Dinaciclib inhibit MCL-1 activity and induce apoptosis in both a MCL-1-dependent and -independent manner. (deposited 28 Jul 2015 12:03) [Currently Displayed]